ZA917747B - Vaccine formulations and their manufacture and use in the treatment of aids - Google Patents

Vaccine formulations and their manufacture and use in the treatment of aids

Info

Publication number
ZA917747B
ZA917747B ZA917747A ZA917747A ZA917747B ZA 917747 B ZA917747 B ZA 917747B ZA 917747 A ZA917747 A ZA 917747A ZA 917747 A ZA917747 A ZA 917747A ZA 917747 B ZA917747 B ZA 917747B
Authority
ZA
South Africa
Prior art keywords
aids
manufacture
treatment
vaccine formulations
vaccine
Prior art date
Application number
ZA917747A
Inventor
Frans Van Wijnendale
Van Wijnendale Frans
Moncef Slaoui
Slaoui Moncef
Claudine Bruck
Bruck Claudine
Suzy Kummert
Kummert Suzy
Myriam Francotte
Francotte Myriam
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of ZA917747B publication Critical patent/ZA917747B/en

Links

ZA917747A 1990-09-28 1991-09-27 Vaccine formulations and their manufacture and use in the treatment of aids ZA917747B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909021175A GB9021175D0 (en) 1990-09-28 1990-09-28 Novel compounds

Publications (1)

Publication Number Publication Date
ZA917747B true ZA917747B (en) 1992-09-30

Family

ID=10682931

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA917747A ZA917747B (en) 1990-09-28 1991-09-27 Vaccine formulations and their manufacture and use in the treatment of aids

Country Status (2)

Country Link
GB (1) GB9021175D0 (en)
ZA (1) ZA917747B (en)

Also Published As

Publication number Publication date
GB9021175D0 (en) 1990-11-14

Similar Documents

Publication Publication Date Title
EP0450624A3 (en) Polymerisable silicic acid heteropolycondensates and their use
IL106109A0 (en) Vaccine compositions and their manufacture
AU1577792A (en) Implantation tissue and treatment and use methods
GB9609932D0 (en) Use of IL-12 and IFN alpha for the treatment of infectious diseases
EP0333344A3 (en) Corneal implants and manufacture and use thereof
HU9202095D0 (en) Therapy and vaccine against aids
EP0499467A3 (en) Use of quinones in the treatment of cancer or aids
EP0453497A4 (en) Treatment methods and vaccines
EP0437026A3 (en) Use of tandospirone in the treatment of depression
GB2203645B (en) Improvements in the treatment of hair
IL91451A0 (en) Pharmaceutical compositions comprising azapiron compounds and their use in the treatment of addiction
GB9027864D0 (en) Pyrimidinyl-and triazinyl-salicylamides and their use and preparation
NZ239183A (en) Peptides antagonistic against bombesin or like proteins and their use in the treatment of disease
ZA917747B (en) Vaccine formulations and their manufacture and use in the treatment of aids
ZA911956B (en) 9-chlor-prostaglandin-beta-cyclodextrin-clathrates and their use as medicinal substances
AU4319393A (en) Use of indolocarbazols in aids treatment
ZA908490B (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
GB9111885D0 (en) Nerve growth factor for use in the prevention and treatment of viral infections
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
GB9022330D0 (en) Aids therapy and vaccine
GB9020999D0 (en) Aids therapy and vaccine
EP0467537A3 (en) Novel benzothiazepine esters, their preparation and formulations for therapeutic use
GB9010190D0 (en) Composition for the treatment of protozoal disease and their use
GB9106540D0 (en) Aids therapy and vaccine
HU9401471D0 (en) Phosphorylated flavonoids in the treatment of viral diseases